Itopride Hydrochloride in Diabetes: Effects on Gastric Emptying and Glycemia
Status:
Completed
Trial end date:
2006-07-01
Target enrollment:
Participant gender:
Summary
Itopride is a new compound that is already marketed in Japan and in some countries of Eastern
Europe under the name of Ganaton. It is used to treat symptoms associated with gastroparesis.
Due to inadequate gastric emptying, these patients often have symptoms of bloating, nausea
and vomiting following ingestion of a meal. The goal of this study is to evaluate the effects
of Itopride on gastric motor function and glycemia in patients with diabetes.